As of 2025-05-19, the Relative Valuation of Maxigen Biotech Inc (1783.TW) is 42.11 TWD. This relative valuation is based on P/E multiples. With the latest stock price at 41.95 TWD, the upside of Maxigen Biotech Inc based on Relative Valuation is 0.4%.
The range of the Relative Valuation is 40.08 - 48.47 TWD.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 22.9x | 20.2x |
| Forward P/E multiples | 18.1x - 20.3x | 18.6x |
| Fair Price | 40.08 - 48.47 | 42.11 |
| Upside | -4.5% - 15.6% | 0.4% |
| Date | P/E |
| 2025-05-02 | 20.42 |
| 2025-04-30 | 20.18 |
| 2025-04-29 | 20.28 |
| 2025-04-28 | 19.76 |
| 2025-04-25 | 20.00 |
| 2025-04-24 | 19.69 |
| 2025-04-23 | 19.83 |
| 2025-04-22 | 19.38 |
| 2025-04-21 | 19.62 |
| 2025-04-18 | 20.23 |
| 2025-04-17 | 19.78 |
| 2025-04-16 | 19.43 |
| 2025-04-15 | 19.15 |
| 2025-04-14 | 18.72 |
| 2025-04-11 | 18.58 |
| 2025-04-10 | 18.72 |
| 2025-04-09 | 17.02 |
| 2025-04-08 | 18.63 |
| 2025-04-07 | 18.56 |
| 2025-04-02 | 20.44 |
| 2025-04-01 | 20.47 |
| 2025-03-31 | 20.28 |
| 2025-03-28 | 21.50 |
| 2025-03-27 | 21.65 |
| 2025-03-26 | 21.91 |
| 2025-03-25 | 21.60 |
| 2025-03-24 | 21.17 |
| 2025-03-21 | 21.39 |
| 2025-03-20 | 21.62 |
| 2025-03-19 | 21.36 |
| 2025-03-18 | 21.62 |
| 2025-03-17 | 21.41 |
| 2025-03-14 | 22.26 |
| 2025-03-13 | 22.24 |
| 2025-03-12 | 22.82 |
| 2025-03-11 | 23.34 |
| 2025-03-10 | 23.77 |
| 2025-03-07 | 23.67 |
| 2025-03-06 | 24.00 |
| 2025-03-05 | 23.39 |
| 2025-03-04 | 25.32 |
| 2025-03-03 | 24.99 |
| 2025-02-27 | 24.85 |
| 2025-02-26 | 23.96 |
| 2025-02-25 | 23.86 |
| 2025-02-24 | 23.63 |
| 2025-02-21 | 23.53 |
| 2025-02-20 | 23.32 |
| 2025-02-19 | 23.34 |
| 2025-02-18 | 23.25 |